In the USA, very little data is available on UITUD. Maternal characteristics and perinatal outcome of 70 ULRTD from Oct.'76 to Nov.'77 were identified. All mothers of UITUD were admitted to Lincoln Hospital within 4 hrs. of delivery. During the same period, there were a total of 3,703 in-hospital deliveries (HD), giving an UWD incidence of 18.5 per 1,000 HD. The main features of lRRiD consist of: 1)59% Black (23% HD); 2)37% more than 24 yrs old (28% HD); 3)17% with parity more than 3 (12% HD); 4)77% on public assistance (43% HD); 5)89%, education below high school (76% HD); 6)58% no prenatal care (19% HD) ; 7)67% broken families (57% HD) ; and 8113% drug-addicted (4% HD) . Low-birth-weight rate (no.f2,500 @/1,000 livebirth), perinatal mortality rate (no. per 1,000 deliveries) and neonatal mortality rate (no./1,000 livebirtt.) associated with UITUD are compared with those of HD as below: During an outbreak of ampicillin-resistant H. influenzae type B (AR-HITB) in a children's chronic care facility, the carriage rates of AR-HITB and ampicillin-sensitive H. influenzae type B (AS-HITB) were studied. Multiple culture surveys were done with 27 to 32 children cultured. As many as 81% carried AS-HITB and as many as 48% carried AR-HITB. Using special media (chocolate agar with 2 mcglml of ampicillin), we found that 30% of the patients carried both strains. Eradication of both strains was attempted by administering trimethoprim-sulfamethoxazole (TMP-SMX) (8 mg140 mg) for five days to all individuals on the ward. At the end of therapy, AS-HITB carriage had been reduced by 80%. AR-HITB were not eradicated from any carrier. Doubling the dose and duration of therapy with TMP-SMX similarly had no effect on AR-HITB carriage. Agar dilution susceptibility studie revealed trailing end points for the majority of AR-HITB isolates. Nearly all AS-HITB isolates had sharp end points. These data suggest that: 1.) TMP-SMX appears to be effective in eradicating nasopharyngeal carriage of AS-HITB; 2.) This drug combination is not effective for AR-HITB carriage; and 3.) Trailing end points on in vitro agar dilution tests may provide evidence for in vivo resistance of AR-HITB to TMP-SMX. 
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